John Barry Landis
Presently, John Barry Landis occupies the position of President for Exelead, Inc. He is also on the board of EyePoint Pharmaceuticals, Inc. and Symphogen An and Member-Chemistry Leadership Council at Purdue University.
In his past career he occupied the position of Chairman of Inotiv, Inc., Vice President at Pharmacia & Upjohn, Inc., Senior Vice President-Pharmaceutical Sciences at Schering-Plough Corp., Senior Vice President-Preclinical Development at The Upjohn Co., Senior Vice President-Preclinical Development at Pharmacia Corp. and Advisory Board at Southwest Michigan First (Venture Capital).
John Barry Landis received a graduate degree and a doctorate from Purdue University and an undergraduate degree from Kent State University (Ohio).
Transactions
Date
Transaction
Value
| 05/13/2019 | 40,000 | Acquisition at $1.74 per share. | 69,600 |
